Your search returned 9 results.

Results
	1.	Cost effectiveness of palivizumab in children with congenital heart disease in Germany. [electronic resource] by Nuijten, Mark Lebmeier, Maximilian Wittenberg, Wolfgang Producer: 20110524 In: Journal of medical economics vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands. [electronic resource] by Nuijten, Mark Lebmeier, Maximilian Wittenberg, Wolfgang Producer: 20110524 In: Journal of medical economics vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis. [electronic resource] by Nuijten, Mark J C Wittenberg, Wolfgang Lebmeier, Maximilian Producer: 20070313 In: PharmacoEconomics vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. [electronic resource] by Salas, Maribel Hughes, Dyfrig Zuluaga, Alvaro Vardeva, Kawitha Lebmeier, Maximilian Producer: 20091110 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK. [electronic resource] by Larkin, James Hatswell, Anthony J Nathan, Paul Lebmeier, Maximilian Lee, Dawn Producer: 20160817 In: PloS one vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria. [electronic resource] by Resch, Bernhard Gusenleitner, Walter Nuijten, Mark J C Lebmeier, Maximilian Wittenberg, Wolfgang Producer: 20081118 In: Clinical therapeutics vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death. [electronic resource] by Hatswell, Anthony J Pennington, Becky Pericleous, Louisa Rowen, Donna Lebmeier, Maximilian Lee, Dawn Producer: 20150528 In: Health and quality of life outcomes vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis. [electronic resource] by Guyot, Patricia Taylor, Peter Christensen, Robin Pericleous, Louisa Poncet, Coralie Lebmeier, Maximilian Drost, Pieter Bergman, Gert Producer: 20121214 In: Arthritis research & therapy vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom. [electronic resource] by Guyot, Patricia Taylor, Peter C Christensen, Robin Pericleous, Louisa Drost, Pieter Eijgelshoven, Indra Bergman, Gert Lebmeier, Maximilian Producer: 20121002 In: The Journal of rheumatology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)